calcium chloride

Trade name: calcium chloride

Small moleculeapproved

Approved

Dec 7, 1953

Calcium chloride is an inorganic compound, a salt with the chemical formula CaCl2. It is a white crystalline solid at room temperature, and it is highly soluble in water. It can be created by neutralising hydrochloric acid with calcium hydroxide. — Wikipedia

Clinical trial activity

26 trials · 27 clinical orgs · 46 marketing orgs

Phase 1
9
Phase 2
8
Phase 3
5
Phase 4
7

Earliest trial started Jun 1, 2006 (NCT00378872)

Timeline

1940s

  1. Jun 1, 1941

    Evidence of US Marketing

1950s

  1. Dec 7, 1953

    Earliest FDA Approval

  2. Dec 7, 1953

    Strides Pharma Science — Marketing Organization

  3. Dec 7, 1953

    DAVA Pharmaceuticals — Marketing Organization

1970s

  1. Mar 22, 1971

    Baxter — First NDA Organization

  2. Mar 22, 1971

    Baxalta — Marketing Organization

  3. Mar 22, 1971

    Baxter — NDA Secondary Org

  4. Mar 22, 1971

    Baxter — NDA Organization

  5. Aug 13, 1975

    ICU Medical Inc — Marketing Organization

  6. Aug 13, 1975

    ICU Medical Inc — NDA Secondary Org

  7. Feb 8, 1978

    B. Braun — Marketing Organization

  8. Feb 8, 1978

    B. Braun — NDA Secondary Org

  9. Sep 5, 1979

    Bristol-Myers — Marketing Organization

1980s

  1. Jan 15, 1980

    Hospira — NDA Secondary Org

  2. Oct 28, 1981

    Nestle — NDA Secondary Org

  3. Feb 14, 1985

    Bristol-Myers Squibb — Marketing Organization

  4. May 9, 1986

    Norbrook — Marketing Organization

  5. Jun 13, 1986

    Abraxis — Marketing Organization

  6. Sep 16, 1986

    West-Ward Pharmaceutical — Marketing Organization

  7. Nov 7, 1988

    Hospira — Marketing Organization

1990s

  1. Oct 15, 1990

    Barr Laboratories — Marketing Organization

  2. Aug 23, 1991

    Pharmacia & Upjohn — Marketing Organization

  3. Nov 27, 1991

    Akorn, Inc. — Marketing Organization

  4. Nov 27, 1991

    Akorn, Inc. — NDA Secondary Org

  5. Nov 27, 1991

    Epic Pharma Llc — NDA Secondary Org

  6. May 15, 1992

    Mylan — Marketing Organization

  7. Jun 13, 1994

    Fresenius — Marketing Organization

  8. Aug 1, 1994

    Hikma — Marketing Organization

  9. Sep 27, 1996

    Lukare Medical — Marketing Organization

  10. Sep 27, 1996

    Lukare Medical — NDA Secondary Org

  11. Jun 17, 1999

    Duramed Research — Marketing Organization

2000s

  1. Apr 21, 2000

    Baxter — Marketing Organization

  2. Oct 25, 2006

    Baxalta — NDA Secondary Org

  3. Apr 30, 2007

    Accord Research — Marketing Organization

  4. Jul 24, 2008

    Alcon — Marketing Organization

  5. Jan 1, 2009

    Earliest Phase 2 Sponsor(trial)

  6. Mar 31, 2009

    Sandoz — Marketing Organization

2010s

  1. Jan 8, 2010

    Pharmachemie Bv — Marketing Organization

  2. Mar 29, 2012

    EXTROVIS — Marketing Organization

  3. Jan 1, 2013

    Earliest Phase 1 Sponsor(trial)

  4. Jan 1, 2014

    Earliest Phase 3 Sponsor(trial)

  5. Aug 25, 2014

    Fresenius — NDA Secondary Org

  6. May 21, 2015

    Sun Pharmaceuticals — Marketing Organization

  7. Jan 13, 2017

    Zydus Discovery DMCC — Marketing Organization

  8. Apr 25, 2017

    Silvergate Pharmaceuticals — Marketing Organization

  9. Apr 25, 2017

    Azurity — Marketing Organization

  10. Jul 27, 2017

    Lutipold — Marketing Organization

  11. Jul 27, 2017

    Sankyo — Marketing Organization

  12. Jul 27, 2017

    Daiichi Sankyo — Marketing Organization

  13. Dec 22, 2017

    Amneal Pharmaceuticals — Marketing Organization

  14. May 9, 2018

    International Medication — Marketing Organization

  15. Aug 9, 2018

    Sagent Pharmaceuticals, Inc. — Marketing Organization

  16. May 1, 2019

    Medefil — Marketing Organization

2020s

  1. Jan 30, 2020

    Eugia Pharma — Marketing Organization

  2. Apr 23, 2021

    Lotus Pharmaceutical — Marketing Organization

  3. Aug 7, 2023

    Daito Pharmaceuticals — Marketing Organization

  4. May 16, 2024

    Elite Laboratories, Inc — Marketing Organization

  5. Jun 3, 2024

    Alembic — Marketing Organization

  6. Dec 17, 2024

    Somerset Pharmaceuticals — Marketing Organization

Indications

Mechanism of action

  • CalciumSupplementation

    Calcium supplementation

Combination products

Approval history

  • approvedPriority reviewDec 7, 1953
  • approvedJun 1, 1941

Chemistry & pharmacology

Loading structure…

SMILES

[Ca+2].[Cl-].[Cl-]
Mol. weight
110.98 g/mol
Chirality
Achiral Molecule
Inorganic
Yes
Polymer
No
Delivery
Parenteral
Availability
Prescription Only

Oral

No

Parenteral

Yes

Topical

No

Sources

Also known as

  • calcium(2+) chloride
  • calcium chloride
  • calcium chloride
  • calcium chloride
  • calcium chloride
  • calcium chloride
  • calcium chloride
  • calcium chloride
  • calcium chloride
  • calcium chloride
  • calcium chloride anhydrous
  • calcium chloride anhydrous
  • calcium chloride, anhydrous
  • calcium chloride, anhydrous
  • calcium chloride dihydrate
  • calcium chloride dihydrate
  • cal plus
  • cal plus
  • e509
  • e509
  • glandosane
  • hypozalix
  • ringerfundin

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT07187544N/ASep 30, 2025Icahn School of Medicine at Mount Sinai, Mount Sinai Hospital, Canada
NCT06378021Phase 3Mar 14, 2024Helwan University, Istanbul University
NCT05973747Early Phase 1 (Phase 1)Sep 1, 2023Stanford University
NCT05027048Phase 3Jan 31, 2023Stanford University
NCT04660721Phase 1/Phase 2 (Phase 2)Dec 31, 2020Sealantium Medical Ltd.
NCT04153435Phase 2Jan 31, 2020Aarhus University, Central Denmark Region
NCT05046262Phase 3Jan 8, 2020Mirai Medical, Ireland, University of Copenhagen
NCT04713319Early Phase 1 (Phase 1)Oct 4, 2019Replicon Health Oy, University of Jyvaskyla
NCT03867383Phase 1/Phase 2 (Phase 2)Mar 15, 2019Stanford University
NCT03772990Phase 4Jan 14, 2019Moscow State University, Vita-Salute University of Milano. Italy
NCT03719001Early Phase 1 (Phase 1)Oct 23, 2018University of California, San Francisco
NCT03771170Phase 4Jan 10, 2018Yuria-Pharm
NCT03824457Phase 4Jan 8, 2018Yuria-Pharm
NCT03133767Phase 4May 1, 2017University of Iowa
NCT04152096Phase 4Jan 24, 2017Yuria-Pharm
NCT02950753Early Phase 1 (Phase 1)Jan 4, 2017University Medical Center of Southern Nevada
NCT03764085Phase 4Dec 6, 2016Yuria-Pharm
NCT03051269Phase 1May 1, 2016University of Copenhagen
NCT02580604Early Phase 1 (Phase 1)Nov 1, 2015University of Colorado, Denver
NCT02461329N/AMay 1, 2015Masaryk University, University Hospital Brno
Showing 20 of 26 trials
Page 1 / 2

Organizations

Research & Development (27)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
Yuria-PharmFor profit4412016
Stanford UniversityAcademic/Hospital3332019
University of CopenhagenAcademic/Hospital3322013
Aarhus UniversityAcademic/Hospital1112020
Central Denmark RegionAcademic/Hospital1012020
Harvard UniversityAcademic/Hospital1112009
Helwan UniversityAcademic/Hospital1112024
Humboldt UniversityAcademic/Hospital1112009
Icahn School of Medicine at Mount SinaiAcademic/Hospital1112025
Istanbul UniversityAcademic/Hospital1012024
Masaryk UniversityAcademic/Hospital1012015
Mirai Medical, IrelandAcademic/Hospital1012020
Moscow State UniversityAcademic/Hospital1112019
Mount Sinai Hospital, CanadaAcademic/Hospital1012025
Palacky UniversityAcademic/Hospital1112014
Replicon Health OyAcademic/Hospital1112019
Sealantium Medical Ltd.For profit1112020
Shahid Beheshti University of Medical SciencesAcademic/Hospital1012015
University Hospital BrnoAcademic/Hospital1112015
University Medical Center of Southern NevadaAcademic/Hospital1112017
27 organizations
Page 1 / 2

Marketing (65)

OrganizationOrg typeRelationshipDate
AbbottFor profitNDA2
AbraxisFor profitMKTGJun 13, 1986
Accord ResearchFor profitMKTGApr 30, 2007
Akorn, Inc.For profitMKTGNov 27, 1991
Akorn, Inc.For profitNDA2Nov 27, 1991
AlconFor profitMKTGJul 24, 2008
AlconFor profitSYNOct 28, 1981
AlembicFor profitMKTGJun 3, 2024
Amneal PharmaceuticalsFor profitMKTGDec 22, 2017
Amneal PharmaceuticalsFor profitSYNJul 8, 2024
AzurityFor profitMKTGApr 25, 2017
B. BraunFor profitMKTGFeb 8, 1978
B. BraunFor profitNDA2Feb 8, 1978
Barr LaboratoriesFor profitMKTGOct 15, 1990
BaxaltaFor profitSYNOct 25, 2006
BaxaltaFor profitMKTGMar 22, 1971
BaxaltaFor profitNDA2Oct 25, 2006
BaxterFor profitNDA2Mar 22, 1971
BaxterFor profitMKTGApr 21, 2000
BaxterFor profitNDAMar 22, 1971
Bristol-MyersFor profitMKTGSep 5, 1979
Bristol-Myers SquibbFor profitMKTGFeb 14, 1985
Bristol-Myers SquibbFor profitSYNApr 14, 1989
DAVA PharmaceuticalsFor profitMKTGDec 7, 1953
Daiichi SankyoFor profitMKTGJul 27, 2017
Daito PharmaceuticalsFor profitMKTGAug 7, 2023
Duramed ResearchFor profitMKTGJun 17, 1999
EXTROVISFor profitMKTGMar 29, 2012
Elite Laboratories, IncFor profitMKTGMay 16, 2024
Epic Pharma LlcFor profitNDA2Nov 27, 1991
Eugia PharmaFor profitMKTGJan 30, 2020
Eugia PharmaFor profitSYNMar 29, 2012
FreseniusFor profitNDA2Aug 25, 2014
FreseniusFor profitMKTGJun 13, 1994
FreseniusFor profitSYNSep 3, 1980
HikmaFor profitMKTGAug 1, 1994
HikmaFor profitSYNSep 16, 1986
HospiraFor profitNDA2Jan 15, 1980
HospiraFor profitMKTGNov 7, 1988
ICU Medical IncFor profitMKTGAug 13, 1975
ICU Medical IncFor profitNDA2Aug 13, 1975
International MedicationFor profitMKTGMay 9, 2018
Lotus PharmaceuticalFor profitMKTGApr 23, 2021
Lukare MedicalFor profitMKTGSep 27, 1996
Lukare MedicalFor profitNDA2Sep 27, 1996
LutipoldFor profitMKTGJul 27, 2017
MedefilFor profitMKTGMay 1, 2019
MilesFor profitNDA2
MylanFor profitMKTGMay 15, 1992
MylanFor profitSYNMar 29, 2012
NestleFor profitNDA2Oct 28, 1981
NorbrookFor profitMKTGMay 9, 1986
Pharmachemie BvFor profitMKTGJan 8, 2010
Pharmachemie BvFor profitSYNJul 8, 1988
Pharmacia & UpjohnFor profitMKTGAug 23, 1991
Sagent Pharmaceuticals, Inc.For profitMKTGAug 9, 2018
SandozFor profitMKTGMar 31, 2009
SandozFor profitSYNMar 31, 2009
SankyoFor profitMKTGJul 27, 2017
Silvergate PharmaceuticalsFor profitMKTGApr 25, 2017
Somerset PharmaceuticalsFor profitMKTGDec 17, 2024
Strides Pharma ScienceFor profitMKTGDec 7, 1953
Sun PharmaceuticalsFor profitMKTGMay 21, 2015
West-Ward PharmaceuticalFor profitMKTGSep 16, 1986
Zydus Discovery DMCCFor profitMKTGJan 13, 2017